<DOC>
	<DOCNO>NCT02112487</DOCNO>
	<brief_summary>Prospective , multi-center , open-label , single-arm , Phase 3b extension study macitentan patient PAH . To assess long-term safety macitentan patient pulmonary arterial hypertension ( PAH ) beyond treatment AC-055-310 study .</brief_summary>
	<brief_title>Extension Psychometric Validation Study ORCHESTRA Patients With PAH</brief_title>
	<detailed_description>To assess long-term safety macitentan patient pulmonary arterial hypertension ( PAH ) beyond treatment AC-055-310 study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Macitentan</mesh_term>
	<criteria>1 . Signed informed consent prior studymandated procedure . 2 . Patients PAH complete ORCHESTRA study ( AC055310 ) schedule 3 . Women childbearing potential ( define ) must : Have negative serum pregnancy test Visit 1 ( i.e. , Visit 4 study AC 055 310 ) agree perform monthly serum pregnancy test . Agree use two reliable method contraception parallel , Visit 1 1 month study drug discontinuation ( see detail ) . A female consider childbearing potential unless meet least one follow criterion : Previous bilateral salpingo and/or oophorectomy , hysterectomy . Premature ovarian failure confirm specialist . Prepubescence , XY genotype , Turner syndrome , uterine agenesis . Postmenopausal , define 12 consecutive month menses without alternative medical cause . Of two contraceptive method must use , one must Group 1 , one must Group 2 , define follow : Group 1 : Oral , implantable , transdermal injectable hormonal contraceptive , intrauterine device , female sterilization ( tubal ligation nonsurgical sterilization , e.g. , permanent contraception Essure procedure ) , partner 's sterilization ( vasectomy ) . If hormonal contraceptive choose group , must take least one month prior enrollment . Alternatively , Essure procedure choose contraceptive method , hysterosalpingogram must perform confirm correct location microinserts tubal occlusion ( per manufacturer 's recommendation ) . Group 2 : Female male condom , diaphragm cervical cap , combination spermicide . Sexual abstinence , rhythm method , contraception partner alone consider acceptable method contraception study . 1 . Patients prematurely discontinue study drug study AC055310 . 2 . Females lactate pregnant ( positive Visit 1 pregnancy test ) plan become pregnant study . 3 . AST and/or ALT 3 X ULN .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>pulmonary arterial hypertension</keyword>
	<keyword>PAH-SYMPACT</keyword>
	<keyword>PAH</keyword>
	<keyword>psychometric instrument</keyword>
</DOC>